-
EP0828504
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0828504
| EP0828504 - METHOD FOR TREATING HUNTINGTON'S DISEASE USING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) PROTEIN PRODUCT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.11.2001 Database last updated on 02.11.2024 | Most recent event Tooltip | 16.11.2001 | Application deemed to be withdrawn | published on 02.01.2002 [2002/01] | Applicant(s) | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks California 91320-1799 / US | [N/P] |
| Former [2000/51] | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1789 / US | ||
| Former [1998/12] | For all designated states AMGEN INC. Amgen Center, 1840 Dehavilland Drive Thousand Oaks, CA 91320-1789 / US | Inventor(s) | 01 /
MARTIN, David 4877 McKinley Drive Boulder, CO 80303 / US | 02 /
MILLER, Gerald, D. 229 Rocky Knob Land Nederland, CO 80466 / US | [1998/12] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [1998/12] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | Application number, filing date | 97916072.8 | 18.03.1997 | [1998/12] | WO1997US04361 | Priority number, date | US19960618543 | 19.03.1996 Original published format: US 618543 | [1998/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9734567 | Date: | 25.09.1997 | Language: | EN | [1997/41] | Type: | A2 Application without search report | No.: | EP0828504 | Date: | 18.03.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.1997 takes the place of the publication of the European patent application. | [1998/12] | Search report(s) | International search report - published on: | EP | 30.10.1997 | Classification | IPC: | A61K38/00 | [1998/12] | CPC: |
A61K38/185 (EP,US);
A61P25/00 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1998/12] | Extension states | AL | 17.11.1997 | LT | 17.11.1997 | LV | 17.11.1997 | RO | 17.11.1997 | SI | 17.11.1997 | Title | German: | VERFAHREN ZUR BEHANDLUNG VON HUNTINGTON'S KRANKHEIT MITTELS EINES AUS EINER GLIAZELLLINIE GEWONNENEM NEUROTROPHEN FAKTOR-PROTEINS (GDNF) | [1998/12] | English: | METHOD FOR TREATING HUNTINGTON'S DISEASE USING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) PROTEIN PRODUCT | [1998/12] | French: | METHODE DE TRAITEMENT DE LA CHOREE DE HUNTINGTON AU MOYEN D'UN PRODUIT PROTEIQUE A BASE DE GDNF | [1998/12] | Entry into regional phase | 17.11.1997 | National basic fee paid | 17.11.1997 | Designation fee(s) paid | 17.11.1997 | Examination fee paid | Examination procedure | 17.11.1997 | Examination requested [1998/12] | 15.02.2001 | Despatch of a communication from the examining division (Time limit: M04) | 28.05.2001 | Application deemed to be withdrawn, date of legal effect [2002/01] | 01.08.2001 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2002/01] | Fees paid | Renewal fee | 11.03.1999 | Renewal fee patent year 03 | 13.03.2000 | Renewal fee patent year 04 | 16.03.2001 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [E]WO9719695 (AMGEN INC [US]) [E] 1,3-10,12-18,20-23 * page 6, line 23 - page 29, line 8 *; | [X]WO9526408 (RHONE POULENC RORER SA [FR], et al) [X] 1-23 * page 6, line 30 - page 10, line 15 *; | [X] - ERNEST ARENAS ET AL., "GDNF PREVENTS DEGENERATION AND PROMOTES THE PHENOTYPE OF BRAIN NORADRENERGIC NEURONS IN VIVO", NEURON, (199512), vol. 15, pages 1465 - 1473, XP002039193 [X] 1,2,10,11,19,21-23 * the whole document * DOI: http://dx.doi.org/10.1016/0896-6273(95)90024-1 | [XP] - E. PEREZ-NAVARRO ET AL., "GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR PROTECTS STRIATAL CALBINDIN-IMMUNOREACTIVE NEURONS FROM EXCITOTOXIC DAMAGE", NEUROSCIENCE, (199611), vol. 75, no. 2, pages 345 - 352, XP002039194 [XP] 1,2,10,11,19,21-23 * the whole document * DOI: http://dx.doi.org/10.1016/0306-4522(96)00336-3 |